Sep 22, 2026 14 0
Uploaded by Guten tag
Favorite
Share
More Options
17
Discovery of SMD-6346 - A Potent, Selective, and Orally Active SMARCA2 Degrader for Targeting SMARCA4-Deficient Human Cancers_Page 1

Open in WPS to view all 17 pages